Metastatic Castration Resistant Prostate Cancer (mCRPC) patients' experience with Radium-223 treatment in Japan - Supplementary Material
收藏数据链接：
官方服务：
资源简介：
Supplementary Table s1: Laboratory parametersSupplementary Table s2: Completion Rate of Ra-223 cyclesSupplementary Table s3: Information QuestionnaireSupplementary Table s4. Minimally important difference (MID) for PRO scales.
提供机构：
Taylor & Francis创建时间：
2024-01-26
